15 results
8-K
EX-99.1
RLYB
Rallybio Corp
9 May 24
Rallybio Reports First Quarter 2024 Financial Results and Provides Business Updates
8:11am
million from Johnson & Johnson Innovation – JJDC, Inc.
In February 2024, Rallybio announced a prioritization of its portfolio and a 45% workforce … to an increase in payroll and personnel-related costs, largely related to severance costs incurred in connection with the workforce reduction, effective
8-K
EX-99.1
RLYB
Rallybio Corp
12 Mar 24
Rallybio Reports Fourth Quarter and Full Year 2023 Financial Results
8:11am
a prioritization of its portfolio and 45% workforce reduction to focus the Company’s resources on its two Phase 2 ready assets, RLYB212, a novel human monoclonal … , Rallybio announced that the Company expects its cash runway to extend into the middle of 2026.
The workforce reduction included 19 roles
8-K
EX-99.1
RLYB
Rallybio Corp
6 Feb 24
Rallybio Announces Portfolio Prioritization and Provides Corporate Update
8:15am
savings, including a 45% workforce reduction, extends cash runway into mid-2026 –
NEW HAVEN, Conn., February 6, 2024 (BUSINESS WIRE) – Rallybio … Corporation (Nasdaq: RLYB) today announced the prioritization of its portfolio and a 45% workforce reduction to focus resources on its Phase 2-ready
8-K
sqhx5me79mt6m8c gwo
6 Feb 24
Rallybio Announces Portfolio Prioritization and Provides Corporate Update
8:15am
10-K
0vv97o
15 Mar 22
Annual report
4:31pm
424B4
w5fofkwku53
30 Jul 21
Prospectus supplement with pricing info
8:28am
S-1/A
019vperln92
22 Jul 21
IPO registration (amended)
4:04pm
S-1
c3y pku9h
2 Jul 21
IPO registration
4:28pm
S-1
EX-10.2
8ex 08rl826ea4f9ms
2 Jul 21
IPO registration
4:28pm
DRS/A
1n6po
7 Jun 21
Draft registration statement (amended)
12:00am
DRS
EX-10.2
oi6p9g
27 Apr 21
Draft registration statement
12:00am
DRS
oivq88n81nysm90
27 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next